Found 595 matching trials
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain N/A Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Show More Learn More & Join Trial
Using ctDNA to Determine Therapies for Lung Cancer PHASE2 This is a study to look at whether the presence of circulating tumour DNA (...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer NA Lung cancer remains the most frequent cause of cancer death in both men and...
Show More Location
Community Regional Medical Center
Learn More & Join Trial
Neoadjuvant Immunotherapy in Brain Metastases PHASE2 The purpose of this phase 2 study is to assess the feasibility and efficacy...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Non-Invasive Ventilation Preoperative Lung Resection Surgery NA Surgical treatment is the standard treatment for localized forms of lung ca...
Show More Location
Centre Hospitalier du Pays d'Aix
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer PHASE2 RATIONALE: Vaccines made from a gene-modified virus and a person's white bl...
Show More Location
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Learn More & Join Trial
Regional Anesthesia and Lung Cancer Recurrence NA Test the effect of combined regiona/general anesthesia on lung cancer recur...
Show More Learn More & Join Trial
Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer Patients Treated With Pembrolizumab N/A The purpose of this study is to learn how to use blood tests to better pred...
Show More Location
Columbia University Irving Medical Center
Learn More & Join Trial
Biomarkers for Risk Stratification in Lung Cancer N/A This is a prospective observational study that will follow patients who und...
Show More Location
Zuckerberg San Francisco General Hospital and Trauma Center
Learn More & Join Trial
A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy PHASE3 ARCH is a randomised, stratified, multicentre, phase III trial. Protocol tr...
Show More Learn More & Join Trial